Cart
sales@molnova.com
IC-9564
CAS No. 174847-98-4
IC-9564( IC9564 | AIDS033640 )
Catalog No. M12649 CAS No. 174847-98-4
IC-9564 (AIDS033640) is a betulinic acid derivative and potent HIV entry inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIC-9564
-
NoteResearch use only, not for human use.
-
Brief DescriptionIC-9564 (AIDS033640) is a betulinic acid derivative and potent HIV entry inhibitor.
-
DescriptionIC-9564 (AIDS033640) is a betulinic acid derivative and potent HIV entry inhibitor that blocks HIV-1 envelope-mediated membrane fusion with IC90 of 0.22 uM for NL4-3 strain; also has IC90s of >5, 2.65, and 1.84 uM for DH012, QZ4734, and HIV-1 89.6, respectively; HIV-1 gp120 plays a key role in the anti-HIV-1 activity of IC9564.
-
In Vitro——
-
In Vivo——
-
SynonymsIC9564 | AIDS033640
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number174847-98-4
-
Formula Weight755.138
-
Molecular FormulaC46H78N2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)CC(C(CC(=O)O)O)NC(=O)CCCCCCCNC(=O)C12CCC(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C(=C)C
-
Chemical Name(3R,4S)-3-Hydroxy-4-[[8-[[(3β)-3-hydroxy-28-oxolup-20(29)-en-28-yl]amino]-1-oxooctyl]amino]-6-methylheptanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Holz-Smith SL, et al. Antimicrob Agents Chemother. 2001 Jan;45(1):60-6.
2. Narumi T, et al. Bioorg Med Chem. 2013 May 1;21(9):2518-26.
3. Sun IC, et al. J Med Chem. 2002 Sep 12;45(19):4271-5.
molnova catalog
related products
-
HIV p17 Gag 77-85
HIV p17 Gag (77-85) is an attractive target for molecular intervention, because it is involved in the viral replication cycle at both the pre- and postintegration levels. In the present experiments, we targeted p17 by intracellularly expressing a cDNA encoding an Ab to p17.
-
Raltegravir
A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
-
Zidovudine
A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.
